Results 31 to 40 of about 6,788,532 (255)

Gut Microbiome in Progressive Multiple Sclerosis

open access: yesAnnals of Neurology, 2021
This study was undertaken to investigate the gut microbiome in progressive multiple sclerosis (MS) and how it relates to clinical disease.
Laura M. Cox   +17 more
semanticscholar   +1 more source

The clinical- and cost-effectiveness of functional electrical stimulation and ankle-foot orthoses for foot drop in Multiple Sclerosis: a multicentre randomized trial [PDF]

open access: yes, 2019
Objective: To compare the clinical- and cost-effectiveness of ankle-foot orthoses (AFOs) and functional electrical stimulation (FES) over 12 months in people with Multiple Sclerosis with foot drop.
Bowers, Roy   +7 more
core   +2 more sources

Digital Twins for Multiple Sclerosis

open access: yesFrontiers in Immunology, 2021
An individualized innovative disease management is of great importance for people with multiple sclerosis (pwMS) to cope with the complexity of this chronic, multidimensional disease.
I. Voigt   +5 more
semanticscholar   +1 more source

Standard versus innovative robotic balance assessment for people with multiple sclerosis: a correlational study

open access: yesEuropean Journal of Medical Research, 2023
Introduction Balance disorders are common in people with Multiple Sclerosis (PwMS) and, together with other impairments and disabilities, often prevent PwMS from performing their daily living activities.
Jessica Podda   +9 more
doaj   +1 more source

Matrix Metalloproteinase-9 and Inflammation in Different Types of Multiple Sclerosis [PDF]

open access: yes, 2016
Different clinical courses of multiple sclerosis, heterogeneity of its clinical implications, different effect of immunomodulatory therapy for the same clinical forms implies various pathogenetic mechanisms of central nervous system damage at this ...
Chernenko, M. (Maksym)   +4 more
core   +2 more sources

The potential of serum neurofilament as biomarker for multiple sclerosis

open access: yesBrain : a journal of neurology, 2021
Multiple sclerosis is a highly heterogeneous disease, and the detection of neuroaxonal damage as well as its quantification is a critical step for patients.
S. Bittner   +4 more
semanticscholar   +1 more source

Coincident onset of multiple sclerosis and herpes simplex virus 1 encephalitis. a case report [PDF]

open access: yes, 2017
Background: Along with vitamin D, smoking, body mass index and others, Epstein Barr virus, other herpesviruses and human endogenous retroviruses represent plausible environmental risk factors for multiple sclerosis.
Buscarinu, M. C.   +7 more
core   +2 more sources

Designing a Self-Perception Cognitive Questionnaire for Italian Multiple Sclerosis Patients (Sclerosi Multipla Autovalutazione Cognitiva, SMAC). A Preliminary Exploratory Pilot Study

open access: yesFrontiers in Neurology, 2021
Background: Although cognition in multiple sclerosis (MS) is assessed by means of several neuropsychological tests, only a few tools exist to investigate patients' perspectives on cognitive functioning.Objective: To develop a new questionnaire aimed at ...
Alice Riccardi   +12 more
doaj   +1 more source

Peripheral blood biomarkers in multiple sclerosis. [PDF]

open access: yes, 2015
Multiple sclerosis is the most common autoimmune disorder affecting the central nervous system. The heteroge-neity of pathophysiological processes in MS contributes to the highly variable course of the disease and unpre-dictable response to therapies ...
Acheson   +298 more
core   +1 more source

Interleukin-33 plasma levels in patients with relapsing-remitting multiple sclerosis

open access: yesBiomolecular Concepts, 2017
Cytokines are implicated in the immunopathogenesis of multiple sclerosis (MS). Interleukin (IL)-33, one of the recently discovered members of the IL-1 superfamily, is a dual functional cytokine involved in various autoimmune disorders.
Alsahebfosoul Fereshteh   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy